electroCore ( NASDAQ: ECOR ) stock rises 9.5% with Q4 and FY guidance, expects FY 2022 revenue o f ~$8.5M ( vs. consensus $8.2M ), representing 68% growth Y/Y.
Government Channels: For the FY of 2022, the company expects to recognize revenue of ~$5.1M pursuant to the Department of Veterans Affairs and Department of Defense originating prescriptions for the Company’s gammaCore products, compared to $3.3M during the full year 2021.
For FY 2022, the company expects to recognize revenue of ~$1.7M from its U.S. commercial channels, which would represent approximately a 158% increase from last year.
Q4 revenue is anticipated to be ~$2.5M, which would represent approximately 68% Y/Y.
December 31, 2022, cash and cash equivalents balance of approximately $18.0
For further details see:
electroCore rises 10% on guiding record revenue for Q4